Financials data is unavailable for this security.
View more
Year on year Elliptic Laboratories ASA had net income fall 15.16% from a loss of 33.00m to a larger loss of 38.00m despite a 31.23% increase in revenues from 52.06m to 68.32m.
Gross margin | -- |
---|---|
Net profit margin | -28.63% |
Operating margin | -36.59% |
Return on assets | -7.15% |
---|---|
Return on equity | -7.81% |
Return on investment | -7.60% |
More ▼
Cash flow in NOKView more
In 2023, cash reserves at Elliptic Laboratories ASA fell by 62.64m. Cash Flow from Financing totalled 2.21m or 3.23% of revenues. In addition the company used 45.51m for operations while cash used for investing totalled 20.97m.
Cash flow per share | -0.06 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 3.02 |
---|---|
Tangible book value per share | 2.40 |
More ▼
Balance sheet in NOKView more
Current ratio | 7.36 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0721 |
---|---|
Total debt/total capital | 0.0673 |
More ▼